je.st
news
AbbVie predicts sharp increase in earnings
2015-01-09 07:00:01| Biotech - Topix.net
AbbVie Inc. predicted sharply higher earnings for the new year, driven by rheumatoid-arthritis drug Humira and the launch of its new hepatitis C virus treatment. The U.S. Food and Drug Administration last month approved the pharmaceutical company's Viekira Pak, an all-oral cocktail of several drugs that showed strong success in treating the liver disease in clinical trials.
Tags: increase
sharp
earnings
predicts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||